Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
1/14/2026
Chinese Scientists Unveil Novel Intratumoral Vaccine
1/14/2026
Caldera Launches with $112.5 Million to Advance China-Licensed IBD Bs...
1/14/2026
Pfizer Announces Completion of Key China Phase 3 Trial for Migraine Dr...
1/14/2026
NHSA Seeks Feedback on Draft Guidelines for Real-World Drug Value Ass...
1/14/2026
Sino Biopharma Completes Full Acquisition of Hygieia for CNY 1.2B
1/14/2026
Signet Thera Raises CNY 80M in Series A
1/14/2026
XellSmart Completes Series C1 Financing
1/14/2026
GenHouse Bio Secures CNY 300M+ in Crossover Financing
1/13/2026
Vibrant Thera Raises $61M to Advance Logic-Gated Cancer Immunotherapie...
1/13/2026
Abbisko's Pimicotinib Advances Toward U.S. Approval as FDA Accepts NDA
1/13/2026
Novartis Expands Radioligand Therapy Pipeline with Licensing Deal from...
1/13/2026
China Weighs Approval of Russian Cancer Vaccine, Eyes Broader Pharma C...
1/12/2026
Anticancer Bioscience Secures Angel Funding to Advance Precision Oncol...
1/12/2026
Eli Lilly Submits Orforglipron NDA in China for GLP-1R Agonist
1/12/2026
AbbVie Secures Global Rights to RemeGen’s PD-1/VEGF Bispecific RC148 ...
1/12/2026
SciNeuro and Novartis Forge $1.5B Collaboration on Next-Gen Alzheimer'...
1/12/2026
Zonsen PepLib Signs $50M Licensing Deal with Novartis for Radioligand ...
1/12/2026
Oricell Raises $70M to Fast‑Track Global CAR‑T Programs
1/12/2026
Zenitar Raises ~CNY 600M in Major Series C Financing
1/12/2026
Recordati Folds Operations in China
1/12/2026
Henlius Reports Promising Phase 2 Results for PD-L1 ADC HLX43
1/9/2026
AirNexis Launches with $200M to Advance China-Origin COPD Therapy
1/9/2026
Recent Executive Moves
1/9/2026
China Rolls Out Smart Medical Insurance Payments to Improve Access
1/9/2026
China Expands Cross-Province Use of Employee BMI Funds for Family Memb...
1/9/2026
NHSA Seeks Comments on Draft Rules for Early Communication on Comparat...
1/9/2026
China Issues New Procedures for Post-Approval Filing Changes to Overse...
1/9/2026
Hengrui Secures China Approval for Retlirafusp Alfa for Gastric Cancer
1/9/2026
MediLink and Roche Expand Partnership with Exclusive Global License fo...
1/8/2026
BMS/Biokin's ADC Hits Phase III Milestone in Advanced NPC
Page:
1
/
59
Total number of articles:
1743
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit